| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
TRH-TSH-THYROID |
Department of Biology (S.I.), University of Rome Roma Tre, 00146 Rome, Italy; Department of Biology (P.D.V., P.L.), University of Rome Tor Vergata, 00133 Rome, Italy; and Department of Cellular and Developmental Biology (S.S., S.L.), University of Rome La Sapienza, 00185 Rome, Italy
Address all correspondence and requests for reprints to: Prof. Sandra Incerpi, Department of Biology, University of Rome Roma Tre, Viale Marconi 446, 00146 Roma, Italy. E-mail: . incerpi{at}uniroma3.it
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In addition to L-T3 and L-T4, other iodothyronines, such as 3,5 diiodo-L-thyronine (3,5 L-T2) and 3,3' diiodo-L-thyronine (3,3'L-T2) are present in biological fluids, but at present it is not clear whether they are derived by peripheral deiodinase activity from thyroid hormones or they play a physiological role into the cell. In fact, these analogs have been reported to be able to mimic some effects of thyroid hormones in mammalian cells. 3,5 L-T2 stimulates oxygen consumption in isolated perfused liver from hypothyroid rats and in mononuclear red blood cells (9). Both 3,5 L-T2 and 3,3'L-T2 stimulate the mitochondrial respiratory rate and cytochrome oxidase activity more rapidly than L-T3, and liver mitochondria have specific binding sites for 3,5 L-T2 (10). Nuclear receptors for these compounds have not been found so far.
We have recently reported the short-term nongenomic effects of thyroid hormones on the stimulation of the Na+/H+ exchanger, in L-6 myoblasts (11). Thyroid hormones also have well known genomic actions on the activity of this transport system in renal brush border membranes of mammalian kidney cells in culture and on the expression of different isoforms of the exchanger in the renal tubule (12, 13, 14). The Na+/H+ exchanger is a plasma membrane protein exchanging extracellular Na+ with cytoplasmic H+ ions according to the concentration gradient; it does not require an energy supply for activity but depends on the Na+/K+-ATPase, the main modulator of the Na+ gradient. Several isoforms of the protein have been reported and identified as NHE1 through NHE6. The NHE1 isoform is present in all mammalian cells and is considered to be the housekeeping isoform of the exchanger family: it is involved in the control of intracellular pH and cell volume (15, 16). The Na+/H+ exchanger has been shown to play a regulatory role in the cell, being activated by phosphorylation with involvement of kinase activities, such as PKC and tyrosine kinase. Therefore, an activation of the exchanger resulting in an increase of intracellular pH may represent the first response of the cell to a wide range of signals (17, 18, 19, 20, 21).
The activity of the Na+/H+ exchanger is supposed to be important for the neutral amino acid transport System A, which is controlled by hormones and growth factors in both adult and fetal cells. Many age-related differences in amino acid uptake regulation have been described in rat hepatocytes following different stimuli (22, 23). The A System carries preferentially alanine, an important gluconeogenetic amino acid in the liver. The alanine transport is Na+ and intracellular pH dependent and is modulated by hormones, growth factors, and substrate availability (24, 25, 26, 27, 28). Activation of System A transport may therefore be linked to modifications of the Na+/H+ exchanger activity (23, 28, 29).
In the present work, we have examined short-term effects of thyroid hormones on the Na+/H+ exchanger and the A System. As an experimental system, we have used chick embryo hepatocytes, isolated at two different stages of development. It is known that the liver is a pivotal target for the genomic effects of thyroid hormones, and about 5% of hepatic genes are under thyroid hormone control (30), but little information is available on the presence and the physiological role of short-term effects in this tissue. Moreover, as thyroid hormones have a relevant role in the prenatal development also in birds, it is important to know whether short-term effects are present during embryonal life and whether they are dependent on developmental stage. Because both the A System and the exchanger activities are activated by growth factors and related to cell proliferation, we have used hepatocytes isolated at 14 and 19 d of embryonal life, which have different proliferation rates (Leoni, S., unpublished observations).
Our results show that thyroid hormones L-T3 and L-T4 activate both transport systems by a nongenomic mechanism but in a differential way: amino acid System A transport is modulated only in the last period of chick embryo development, whereas the Na+/H+ exchanger is stimulated in both 14- and 19-d-old hepatocytes; furthermore, the dose-response of activation by thyroid hormone is different for the two transport systems. The 3,5 diiodothyronine is able to mimic the hormonal response only as far as the Na+/H+ exchanger is concerned, being totally ineffective on amino acid transport. The stimulation of these transport systems by thyroid hormones and 3,5 L-T2 involves PI 3K, MAPK pathway, and PKC.
| Materials and Methods |
|---|
|
|
|---|
Amino acid transport
For the amino acid transport assay, AIB was used (specific activity 4060 µCi/µmol). Chick embryo hepatocytes, kept at 37 C and oxygenated (5% CO2 and 95% air), were incubated 10 min in Krebs-Henseleit solution with and without Na+, containing 0.1 µCi (10 µM final concentration) of the labeled amino acid in the presence of different concentrations of thyroid hormones. In the sodium-free medium, sodium chloride and bicarbonate were replaced by equimolar choline salts (24). For experiments in the presence of activators and inhibitors of PKC and PI3K, and of MAPK pathway, these were added 10 min before the addition of thyroid hormones or analogs. At the end of incubation, cells were rinsed twice with cold phosphate buffer and disrupted in 200 µl NaOH (0.2 M) and then kept at 100 C for 30 min. Aliquots were taken and the radioactivity was measured, after the addition of Optifluor, in a liquid scintillation spectrometer (Packard Instruments, Downers Grove, IL). The Na+-dependent component of AIB transport was determined by subtracting the AIB uptake in the absence of sodium from the uptake in its presence. The Na+-dependent uptake was linear up to 15 min. The protein content of each sample was evaluated by the method of Lowry (32).
Determination of intracellular pH
For the fluorescence assays, cells were seeded (about 2 x 105 cells/well) in collagen-coated chamber slides (Lab-Tek, Nunc, Naperville, IL) and used at confluency, after 48 h from seeding.
Intracellular pH was measured by the fluorescent intracellular pH indicator 2',7'-bis-(2-carboxyethyl)-5(and-6)-carboxyfluorescein acetoxymethyl ester (BCECF/AM) as already reported (11). To rule out the contribution of HCO3--dependent transport mechanisms (33), all experiments were carried out in bicarbonate-free buffer with the following composition (mM): 135 NaCl, 5 KCl, 1 CaCl2, 1 MgCl2, 10 glucose, and HEPES (pH 7.3). This buffer (henceforth reported as Na+ buffer) was used for the incubation with the fluorescent probe and for the determination of intracellular pH, unless otherwise stated; the cells incubated in this buffer were considered virtually depleted of bicarbonate.
The experiments with acid load were carried out as already reported (11): solutions containing NH3/NH4+ were prepared from the above mentioned buffer where 20 mM NaCl was replaced with 20 mM NH4Cl, and the remaining external Na+ was routinely replaced by equimolar choline chloride to keep the antiport quiescent.
Routinely at the end of each experiment, calibration of fluorescence vs. pH was carried out by the well established nigericin method (34). The calibration curve was linear in the pH range 6.57.8 (not shown).
Fluorescence was measured under continuous magnetic stirring at a controlled temperature (37 C) in a Perkin-Elmer Corp. (Shelton, CT) LS-5 luminescence spectrometer equipped with a chart recorder model R 100A, with excitation and emission wavelengths of 500 and 530 nm, using 5- and 10-nm slits, respectively, for the two light paths.
Determination of intrinsic ßi
The total intracellular buffering capacity (ßt) is defined as follows:
. In the nominally HCO3--free solutions used in this study, ßCO2 was assumed to be negligible and ßt was therefore taken to be equal to ßi, which was determined by the NH4+ pulse technique, as previously described (Ref. 11 ; for a review see Ref. 35) according to the formula:
![]() |
where
[NH4+]i represents the change in concentration of intracellular NH4+ after exposure to or removal of extracellular NH3 and
pHi represents the corresponding change in pHi.
Solutions
BCECF/AM (1 mg/ml), amiloride (10 mM), 5-(N-ethyl-N-isopropyl) amiloride (EIPA, 10 mM), 2'amino-3'methoxyflavone (PD 98059), phorbol 12-myristate 13-acetate (PMA), wortmannin, bisindolylmaleimide IX methanesulfonate (RO 31-8220), and 4,4'-diisothiocyano-stilbene-2,2'-disulfonic acid (DIDS) were dissolved in dimethyl sulfoxide, which did not affect the fluorescence signal and in any case its concentration in the presence of cells did never exceed 0.1%. Nigericin (10 mM) was dissolved in ethanol. Thyroid hormones and analogs were dissolved in 0.1 M NaOH. 6-n-Propyl-2-thiouracil (PTU, 1 mM) was an aqueous solution.
Materials
Collagenase (type D) was purchased from Roche Molecular Biochemicals (Mannheim, Germany). [1-14C]2-Aminoisobutyric acid was from NEN Life Science Products (Boston, MA). Roswell Park Memorial Institute 1640 medium and FCS were from HyClone Laboratories, Inc. (Logan, UT). BCECF/AM was obtained from Molecular Probes, Inc. (Eugene, OR). Nigericin, HEPES, MES, Tris(hydroxymethyl) aminomethane, 3,3',5-triiodo-L-thyronine sodium salt (L-T3), 3,3',5,5'-tetraiodo-L-thyronine (L-thyroxine or L-T4), 3,5-diiodo-L-thyronine (3,5 L-T2), D-thyroxine (D-T4), PMA, wortmannin, RO 31-8220, amphotericin, gentamicin and collagen were supplied by Sigma (St. Louis, MO). EIPA was obtained from Research Biochemicals International (Natick, MA). 3,5,3'-Triiodo-D-thyronine (free acid, D-T3), DIDS and PTU were from ICN Pharmaceuticals, Inc. (Costa Mesa, CA). PD 98059 was from Alexis Biochemicals (Laufelfingen, Switzerland). All other chemicals were of purest grade available from Merck \|[amp ]\| Co., Inc. (Darmstadt, Germany).
| Results |
|---|
|
|
|---|
The dose-response of thyroid hormones (L-T3 and L-T4) and 3,5 L-T2 on the activation of the Na+/H+ exchanger at the steady state is shown in Fig. 1
. Both hormones stimulated the Na+/H+ exchanger in a wide concentration range with a maximum increase of intracellular pH at 1 nM for both 14- and 19-d-old cells, after 15 min, and a minor effect at higher and lower concentrations. L-T4 and L-T3 gave rise to an increase of intracellular pH of about 0.20 U pH/15 min over basal value for 19-d-old hepatocytes and about 0.15 U pH/15 min for the 14-d-old cells, well in agreement with the effect on the intracellular pH in L-6 myoblasts from rat skeletal muscle (11). The 19-d-old cells were more responsive to thyroid hormones than the 14-d-old cells, in particular, the difference in response to L-T3 was significant between the two stages. Because the 3,5 L-T2 has been reported to be able to mimic some nongenomic effects of thyroid hormones in liver mitochondria (10), we wanted to verify whether this analog of thyroid hormone might play a functional role also in chick embryo hepatocytes. The dose-response of 3,5 L-T2 in a wide concentration range on the activation of the Na+/H+ exchanger showed a significant increase in intracellular pH (Fig. 1C
), with a maximum at 1 nM of 0.11 ± 0.02 pH units/15 min (mean ± SD; n = 3) over the basal value for the 14 d, whereas the maximum increase for the 19 d was 0.12 ± 0.02 pH units/15 min (mean ± SD; n = 4). The effect of both hormones and 3,5 L-T2 was inhibited by EIPA, an amiloride derivative and specific inhibitor of the Na+/H+ exchanger, confirming the specificity of thyroid hormone/analog action on the Na+/H+ exchanger (Fig. 2
). Even though a HCO3--free buffer has been used throughout the experiments, we cannot rule out possible HCO3- production in metabolically active hepatocytes. However, experiments in the presence of DIDS (0.1 mM), an inhibitor of Na+dependent HCO3- transport systems indicate that the contribution of this transport system to the increase of intracellular pH by both thyroid hormones and 3,5 L-T2 is negligible for the 19-d-old cells (Fig. 2
). As to the 14-d-old cells, it was not possible to measure properly the activity of the exchanger in the presence of DIDS because this compound affected cell viability at concentrations as low as 15 µM.
|
|
L-T4 is nowadays considered as a pro-hormone that is converted to the active form, L-T3 by different deiodinase activities, reported to be present also in chick embryo hepatocytes (37). In particular, type 1 iodothyronine deiodinase (D1) is expressed in the liver and is considered responsible for the production of circulating L-T3. The amount of active D1 enzyme increases 2- to 3-fold between d 14 and 18 of incubation, and remains stable afterwards (37). Therefore, chick embryo hepatocytes at different stages of development were pretreated 20 min at 37 C with the 5'-deiodinase inhibitor PTU (10 nM), then the effect of L-T3 and L-T4 on intracellular pH was tested (Fig. 3
). As expected, PTU did not affect the functioning of L-T3, whereas the effect of L-T4 was partially suppressed (5070%). The inhibition appeared to be less efficient in 19-d-old cells. Stronger inhibition was observed at high PTU concentrations, but under those conditions cell viability was affected; the results were no longer considered reliable and are not included.
|
|
Transduction pathways involved in the activation of the Na+/H+ exchanger by thyroid hormones
Some experiments were made to assess the involvement of kinase activities in the stimulation of the Na+/H+ exchanger in chick embryo hepatocytes, using inhibitors of PKC, MAPK, and PI3K. The treatment with the PKC inhibitor RO 318220 prevented the thyroid hormone stimulation of the Na+/H+ exchanger at both stages of development, even though the 14-d-old hepatocytes were less sensitive to the inhibitor treatment than 19-d-old cells. The inhibitors of PI3K, wortmannin, and of MAPK pathway, PD 98059, also gave rise to significant inhibition in all cases suggesting a role for these three kinases in the mediation of the stimulation of Na+/H+ exchanger in both 14-d-old and 19-d-old chick embryo hepatocytes (Fig. 5
). From a careful inspection of Fig. 5
, it appears that wortmannin was less effective in the inhibition of both L-T3 and 3,5 L-T2 with respect to L-T4 (P < 0.05, at least as from a t test). In fact, about 25% of the effect of L-T3 on intracellular pH was retained after wortmannin treatment.
|
of PKC by overnight incubation with PMA (10 µM) confirmed the role of this kinase, or at least of isoform
of PKC, in the mediation of rapid effects of L-T3 on the exchanger in both 14- and 19-d-old hepatocytes (Fig. 6
|
|
|
|
| Discussion |
|---|
|
|
|---|
The activation by a nongenomic mechanism of the Na+/H+ exchanger in L-6 rat myoblasts has previously been reported by some of us (11). In chick embryo hepatocytes it appears that both L-T3 and L-T4 are more effective at the late stage of embryonal development, when the embryo is close to term. The 3,5 L-T2 which is able to mimic some nongenomic actions of thyroid hormones (9), is also able to activate the Na+/H+ exchanger, although with a minor efficiency with respect to L-T3. The specificity of the effect was assessed by the use of inhibitors of the exchanger such as EIPA, and by the use of the most common thyroid hormone analogues. Our data with DIDS, an inhibitor of the Na+-dependent HCO3- transporter, indicate that this system is not significantly involved in the increase of pHi elicited by thyroid hormones in chick embryo hepatocytes.
The higher sensitivity to thyroid hormones in the cells close to term is in agreement with the higher activity of 5'-deiodinase (type 1, D1) in the chick embryo at this stage, with respect to an earlier stage of development (37). However, the remaining 3050% of the effect might actually be due to L-T4, as described below. An appropriate level of thyroid hormone is essential for normal development in vertebrate species. This appears to be particularly relevant in humans, where deficiency of thyroid hormone in the central nervous system during fetal development or the neonatal period results in mental retardation and cretinism. Also the exposure of the embryo to excessive thyroid hormone levels is detrimental, and may likewise result in fetal malformation, growth and mental retardation (38). In this context, the bell-shaped dose-response curve of thyroid hormones on the Na+/H+ exchanger activation is particularly intriguing. In fact, the lower sensitivity of the transporter to high hormone concentration could be a protection mechanism against excessive exposure of these cells to high hormone levels, as already reported for other hormones (39, 40).
The acid load experiments in 19-d-old fetal hepatocytes indicate that L-T3 increases the rate of recovery of the steady-state pH, adjusting the set point to a new value. As a consequence the net efflux acid (J) is increased, as in mammalian cells (11). At variance with these results the 14-d-old hepatocytes were completely insensitive to the acid load with ammonium chloride. It is interesting to speculate about the significance of these findings. First, chick embryo hepatocytes appear to be less sensitive to the acid load with respect to mammalian cells, showing a high buffering capacity of about 100 mM/pH, as already reported for other cell types from avian tissue (38). It seems that these cells have a higher capacity of preserving intracellular pH. In fact, alterations of intracellular pH is a treatment that disrupts embryo development in vitro (41), and therefore the maintenance of an appropriate intracellular pH may be a pivotal feature for embryo survival. Second, thyroid hormone increases the net acid efflux and this might contribute to the ability of the cell to maintain the intracellular pH or, since the exchanger mediates electroneutral exchange of 1 Na+ for 1 H+, it might also contribute to preserve intracellular sodium ions, a behavior which in land birds seems to be of great physiological relevance (42).
The lack of a significant difference in the stimulatory effectiveness of thyroid hormones on the exchanger at both stages of embryonal development, suggests that the activation of this transport system is not related to the proliferative activity of the hepatocytes, which is significantly different in the two stages of development (our unpublished observations).
At variance with the Na+/H+ exchanger, the activation of AIB transport by thyroid hormones appears related to the proliferative activity and to the stage of embryonal development, being highly significant at 19 d when the embryo is close to term and insensitive to thyroid hormones at the 14-d stage. L-T3 and L-T4 appear to be able to activate this transport system in the physiological range, whereas 3,5 L-T2 shows little effect and only when added at very high concentrations (not shown). The dependence of the hormonal control of System A on development has previously been observed in these cells upon treatment with EGF; it is also found in fetal rat hepatocytes treated with EGF, insulin, glucagon, or epinephrine, and can be related to the different distribution of these cells in the phases of cell cycle (27, 28, 43).
The System A amino acid transport is believed to be dependent on intracellular pH (27, 29), and it is therefore very interesting that our results clearly demonstrate that System A activity is not directly correlated with pHi. In fact, high levels of thyroid hormones do not lead to an increase in pHi but still give the largest increase in AIB transport capacity. This observation suggests that System A is not controlled directly through pHi, but rather through a receptor-based signal transduction pathway, which also activates the Na+/H+ exchanger.
The signal transduction pathways of the short-term effects of thyroid hormones are not known, but recent papers indicate an involvement of PKC, PI3K, and MAPK pathway (4, 5). Because both Na+/H+ exchanger and amino acid transporter may be modulated by PKC and by PI3K products (28, 44), we studied the involvement of these kinases by a pharmacological approach, and our data indicate the involvement of all three kinases in the mediation of nongenomic actions of thyroid hormones. Some authors have reported that the activity of NHE1 and NHE3 isoforms of the exchanger are regulated by PI3K and by its products, as it contains binding sites for PIP2 (44). The PI3K is important for the translocation to the cell membrane from intracellular vesicles of some transporter systems, and the Na+/H+ exchanger may be one of these (44). In our cells, wortmannin, a potent inhibitor of this kinase, gives rise to a net decrease of the stimulation by thyroid hormones of both the Na+/H+ exchanger, reduced by about 75% with slight differences between L-T3 and L-T4, and the amino acid transport, suggesting that these hormones activate PI3K. But the different extent of inhibition for L-T4 and L-T3 in the two transport systems also suggests differences in the transduction pathways between the two hormones. This point deserves further investigation and it is now under study in our laboratory.
In conclusion, the Na+/H+ exchanger and the System A amino acid transport show different short-term modulation by thyroid hormones. First of all, the dose-response to thyroid hormones shows a bell-shaped curve for the exchanger, whereas it is linear for the amino acid transport; second, the response of the exchanger to the hormones already appears in 14-d-old cells, whereas the amino acid transport is activated only at 19 d of fetal development; third, 3,5 L-T2 mimics the thyroid hormone effect on the Na+/H+ exchanger, but not on the amino acid transport. The nongenomic actions of thyroid hormones are present in avian hepatocytes during prenatal life and probably play an important role during development and terminal differentiation, with a rapid regulation of intracellular pH, Na+ flux and amino acid transport.
| Acknowledgments |
|---|
| Footnotes |
|---|
Abbreviations: AIB, [1-14C]2-aminoisobutyric acid; BCECF/AM, 2',7'-bis-(2-carboxyethyl)-5(and-6)-carboxyfluorescein acetoxymethyl ester; DIDS, 4,4'-diisothiocyano-stilbene-2,2'-disulfonic acid; EIPA, 5-(N-ethyl-N-isopropyl) amiloride; PMA, phorbol 12-myristate 13-acetate; PTU, 6-n-propyl-2-thiouracil.
Received November 2, 2001.
Accepted for publication January 3, 2002.
| References |
|---|
|
|
|---|
5ß1 integrin expression and function. Atherosclerosis 154:377385[CrossRef][Medline]
. Cell Physiol Biochem 10:209218[Medline]
This article has been cited by other articles:
![]() |
G. Fava, Y. Ueno, S. Glaser, H. Francis, S. DeMorrow, L. Marucci, M. Marzioni, A. Benedetti, J. Venter, B. Vaculin, et al. Thyroid hormone inhibits biliary growth in bile duct-ligated rats by PLC/IP3/Ca2+-dependent downregulation of SRC/ERK1/2 Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1467 - C1475. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Moeller, A. M. Dumitrescu, and S. Refetoff Cytosolic Action of Thyroid Hormone Leads to Induction of Hypoxia-Inducible Factor-1{alpha} and Glycolytic Genes Mol. Endocrinol., December 1, 2005; 19(12): 2955 - 2963. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Giudetti, M. Leo, M. J. H. Geelen, and G. V. Gnoni Short-Term Stimulation of Lipogenesis by 3,5-L-Diiodothyronine in Cultured Rat Hepatocytes Endocrinology, September 1, 2005; 146(9): 3959 - 3966. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Incerpi Thyroid Hormones: Rapid Reply by Surface Delivery Only Endocrinology, July 1, 2005; 146(7): 2861 - 2863. [Full Text] [PDF] |
||||
![]() |
X. Cao, F. Kambe, L. C. Moeller, S. Refetoff, and H. Seo Thyroid Hormone Induces Rapid Activation of Akt/Protein Kinase B-Mammalian Target of Rapamycin-p70S6K Cascade through Phosphatidylinositol 3-Kinase in Human Fibroblasts Mol. Endocrinol., January 1, 2005; 19(1): 102 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D'Arezzo, S. Incerpi, F. B. Davis, F. Acconcia, M. Marino, R. N. Farias, and P. J. Davis Rapid Nongenomic Effects of 3,5,3'-Triiodo-L-Thyronine on the Intracellular pH of L-6 Myoblasts Are Mediated by Intracellular Calcium Mobilization and Kinase Pathways Endocrinology, December 1, 2004; 145(12): 5694 - 5703. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lei, C. N. Mariash, and D. H. Ingbar 3,3',5-Triiodo-L-thyronine Up-regulation of Na,K-ATPase Activity and Cell Surface Expression in Alveolar Epithelial Cells Is Src Kinase- and Phosphoinositide 3-Kinase-dependent J. Biol. Chem., November 12, 2004; 279(46): 47589 - 47600. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Tang, H.-Y. Lin, S. Zhang, F. B. Davis, and P. J. Davis Thyroid Hormone Causes Mitogen-Activated Protein Kinase-Dependent Phosphorylation of the Nuclear Estrogen Receptor Endocrinology, July 1, 2004; 145(7): 3265 - 3272. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Incerpi, S. D'Arezzo, M. Marino, R. Musanti, V. Pallottini, A. Pascolini, and A. Trentalance Short-Term Activation by Low 17{beta}-Estradiol Concentrations of the Na+/H+ Exchanger in Rat Aortic Smooth Muscle Cells: Physiopathological Implications Endocrinology, October 1, 2003; 144(10): 4315 - 4324. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||